Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Onco-Innovations Ltd. ( (TSE:ONCO) ) has provided an update.
Onco-Innovations Ltd. has completed its acquisition of Inka Health Corp., enhancing its capabilities in AI-driven cancer research and drug development. This strategic acquisition aims to integrate Inka Health’s SynoGraph™ platform to accelerate precision oncology and streamline drug discovery processes. The acquisition is expected to strengthen Onco’s operations and position in the industry, backed by Inka’s established partnerships with leading firms like AstraZeneca Canada.
More about Onco-Innovations Ltd.
Onco-Innovations Ltd. operates in the biotechnology industry with a focus on cancer research and drug development. The company leverages advanced AI-driven analytics to enhance precision oncology, aiming to accelerate cancer detection, research, and treatment development.
YTD Price Performance: 140.0%
Average Trading Volume: 396,872
For a thorough assessment of ONCO stock, go to TipRanks’ Stock Analysis page.
